Diabetes Drug Linked to Serious Heart Risks - by Lynn Fugaro Avandia, generic rosiglitazone, was approved in 1999 by the FDA (Food and Drug Administration) to treat type 2 diabetes. It is estimated that approximately six million people take the drug worldwide...
